Research workbench
Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from rana pipiens oocytes
Analyse Enzymatic and structural characterisation of amphinase, a novel cytotoxic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 2P7S
- Type
- protein
- Length
- 110 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Amphinase-2
- EC
- 3.1.27.-
- UniProt
- P85073
- Ligands
- NAG
Structure
x-ray diffraction · 1 distinct chain · 20% helix, 41% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Amphinase-2 (EC 3.1.27.-) | protein | 110 | 20% helix, 41% strand | P85073 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
- ACT · Acetate ion · additive · 2 copies · chains A
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Modifications
Observed in the structure: 4 disulfide, 1 glycan (disulfide, N-glycosylation).
Compared structures
- 2P7S · Enzymatic and Structural Characterisation of Amphinase, a Novel Cytotoxic Ribonuclease… · the same entry in another collection · chain A against A, TM-score 1.00
- P85073 · AlphaFold monomer V2.0 prediction for amphinase-2 (P85073) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P85073
- Elsewhere: RCSB PDB 2P7S · PDBe 2P7S · UniProt P85073
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.